Bioage Labs (FRA:Y7G) Preferred Dividends: €0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:Y7G Bioage Labs Inc FRA:Y7G
12 GF Score
Price €9.06
! 3 Warning Signs
View Full Analysis

What is Bioage Labs Preferred Dividends?

Bioage Labs FRA:Y7G -7.17% 12 Preferred Dividends is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:Y7G with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Bioage Labs's preferred dividends for the three months ended in Jun. 2026 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2026 was €0.00 Mil.

Bioage Labs  (FRA:Y7G) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Bioage Labs's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs Preferred Dividends Chart

Bioage Labs Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Preferred Dividends
0.00 0.00 0.00 0.00

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:Y7G
12GF Score
Bioage Labs Inc FRA:Y7G
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioage Labs Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of €0.00 Mil mean?
Bioage Labs (FRA:Y7G) has a Preferred Dividends of €0.00 Mil as of Jun. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Bioage Labs and its competitors.
Is Bioage Labs' Preferred Dividends too high?
Bioage Labs' current Preferred Dividends is €0.00 Mil. Overall, Bioage Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioage Labs' Preferred Dividends compare to PCRX and ALVO?
Bioage Labs' Preferred Dividends of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Drug Manufacturers company?
A good Preferred Dividends depends on the Drug Manufacturers industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Bioage Labs and its competitors. Bioage Labs's current Preferred Dividends is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioage Labs stock overvalued right now?
Bioage Labs (FRA:Y7G) has a current Preferred Dividends of €0.00 Mil. The current Preferred Dividends is €0.00 Mil. Bioage Labs' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Bioage Labs (FRA:Y7G), the current Preferred Dividends is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioage Labs Business Description

Other Exchanges BIOA:USA
Address 1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
12GF Score

Get the complete analysis for FRA:Y7G

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.06
Price